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Purification Process Development of Protein Subunit 
based Vaccine Candidates Produced using 
Recombinant E. coli Expression System-Case Study
ABSTRACT
Introduction and Objective
•The concept of Platform Technology (capturing, purification and 
polishing) has been successfully applied to the Mab purification 
(Figure 1).
•The objective of this study was to assess whether a similar concept 
can be applied to the purification of E. Coli expressed soluble 
recombinant proteins in order to facilitate vaccine antigen purification 
process development.  
•A case study with a specific challenge will also be discussed (Part II)
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Methods
•Chromatographic methods such as Anion or cation exchange, 
Hydrophobic interaction chromatography, mixed mode chromatography 
methods were used.
•AKTA Explorer was used for small-scale method development and 
processes were scaled-up using AKTA PILOT.
•In-Process samples were tested using inline monitoring by UV, 
conductivity etc.
•Fractions were analyzed by SDS-PAGE or BCA protein assay.
Conclusions
•Several protein purification processes were developed using different 
protein antigens expressed in E. coli expression systems.
•A trend was observed in most of these purification schemes i.e. strong 
anion exchange such as Q column worked well as primary capture step 
and had enough capacity to capture the target protein where the 
expression in upstream was 1-3 g/L (Figure 1)
•Binding and elution conditions of each protein including the buffers to 
purify these protein varied and were dependent on the individual
characteristics of these proteins (data not shown).
•The purity of in-process fractions after 1st unit operation was typically 
>50%. (Figure 2)
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Figure 2: SDS-PAGE Analysis of 
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Results (2)
•The 2nd unit operation selected 
was either a cation exchanger 
(such as SP) or Hydrophobic 
column chromatography (HIC) 
step.
•The purity of in-process 
samples after 2 unit operation 
was typically >80% and for one 
protein was even >90% (Figure 
3).
•Binding and elution conditions 
of each protein including the 
buffers to purify these proteins 
on cation exchanger or HIC 
varied and were dependent on 
the individual characteristics of 
these proteins (data not shown).
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Figure 3: SDS-PAGE Analysis of 
Fractions from 2nd unit operation
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•The 3rd unit operation selected was 
almost always a mixed mode column 
chromatography step such as 
Ceramic Hydroxyapatite or Q 
membrane. The purity of in-process 
samples after 3 unit operation was 
typically >95% and met the criteria 
(Figure 4).
•Binding and elution conditions of 
each protein including the buffers to 
purify these proteins on  3rd column 
were dependent on the individual 
characteristics of these proteins 
(data not shown).
•Three or two column purified 
material was used for final buffer 
exchange using Tangential Flow 
Filtration.
Results (3)
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Figure 4: SDS-PAGE 
Analysis of Fractions 
from 3rd unit operation
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4= Flow Through
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Results (1)
A common theme or the standardized approach can 
be used to develop new purification processes for new 
recombinant E. Coli antigens (Figure 5).
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Figure 5: Common theme in the purification of soluble 
recombinant proteins in E. Coli
Part I
Proteins are key components of prophylactic vaccines against 
infectious diseases. Protein subunit based vaccine is an attractive 
alternative to the traditional detoxified bacterial or inactivated viral 
vaccine approach due to its highly purified and well characterized 
product nature. Purification of protein antigens to achieve consistent 
product purity and quality is an integral part of the protein subunit 
vaccine product development process.  Expression levels of the 
recombinant proteins in bacterial expression system may be 
extremely high following rapid technology advancement. The 
challenges and approaches used to develop purification processes for 
novel protein vaccine candidates expressed at g/L level are being 
discussed.
